In The News Posted September 27, 2021 Share Posted September 27, 2021 - L'essai pivot de phase 3 a atteint tous les critères d'évaluation principaux, démontrant la non-infériorité du vaccin quadrivalent antigrippal autorisé aux États-Unis - Le candidat vaccin NanoFlu™ induit des réponses immunitaires à médiation cellulaire significativement améliorées - Le...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now